SGK|Targetmol

Cat No.	product name
T2356	Ro 3306	RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinase...
T2482	AT13148	AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II.
T2622	GSK650394	GSK650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.
T6057	URMC-099	URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM...
T6635	EMD638683	EMD638683,a novel SGK inhibitor with antihypertensive potency(with an IC50 of 3 μM).
T11181	EMD638683 R-Form	EMD638683 is a highly selective SGK1 inhibitor with IC50 of 3 μM. EMD638683 R-Form is the R-form of EMD638683.

Ro 3306

T2356CAS 872573-93-8

RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinase...

AT13148

T2482CAS 1056901-62-2

AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II.

GSK650394

T2622CAS 890842-28-1

GSK650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.

URMC-099

T6057CAS 1229582-33-5

URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM...

EMD638683

T6635CAS 1181770-72-8

EMD638683,a novel SGK inhibitor with antihypertensive potency(with an IC50 of 3 μM).

EMD638683 R-Form

T11181CAS 1184940-47-3

EMD638683 is a highly selective SGK1 inhibitor with IC50 of 3 μM. EMD638683 R-Form is the R-form of EMD638683.